SLSNSOLESENCE, INC.
Health Care
Operating Income (Loss) revised up 29.6% for Q2 2025
This is the 7th largest revision in SLSN's history.
Operating Income (Loss)·Q2 2025
Major restatement$2.5M▲ 29.6%
was$1.9M
Revised up in a 10-Q.
Verify against SEC filingsShow
As reported$1.9M
Accepted 2025-08-140001999371-25-011366
Restated$2.5M
Accepted 2026-08-190001999371-26-018231
OperatingIncome · reported 2 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time SLSN — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.